Genmab A/S
Denmark
435 articles about Genmab A/S
-
Genmab A/S Announces Year End 2005 Financial Results
2/16/2006
-
Genmab A/S Licenses Angiogenesis Targets From Bionomics Limited
2/14/2006
-
Genmab A/S's HuMax-EGFr Awarded Fast Track Status From FDA
1/3/2006
-
Genmab A/S Appoints Annarie Lyles As Head Of Business Development
1/3/2006
-
Roche Files IND For Genmab (GNMSF.PK) Antibody
12/13/2005
-
Genmab A/S Release: HuMax-CD20 Induces Rapid Responses In Relapsed CLL Patients
12/13/2005
-
Genmab A/S Release: HuMax-CD38 Effective In Preclinical Studies
12/12/2005
-
Genmab A/S Announces Responses With HuMax-CD4(TM) In Non-Cutaneous T-Cell Lymphoma
12/12/2005
-
Genmab A/S Announces Data On All Evaluable Patients In HuMax(R)-CD20 NHL Phase I/II Study
12/1/2005
-
Genmab A/S Announces Results For The First Nine Months Of 2005
11/8/2005
-
Genmab A/S Receives Patent For HuMax-HepC
11/3/2005
-
The Day In Review: Biotech Rises Again
5/18/2005
-
Genmab Licenses HuMax-TAC To Serono In Deal Worth Up To $40M
5/4/2005
-
James D. Watson Helix Awards Honor Biotech's Top Performers
2/24/2005
-
Genmab A/S's HuMax-CD4 Receives EU Orphan Drug Designation
5/26/2004